Deals·October 20, 2026 at 8:00 AM EDT·5 sources
OpenAI acquires startup Orchestra Bio to beef up its biotech business
Outlets covering it5 in 10 hours
Oct 20, 12 PMOct 20, 9 PM
What happened
- OpenAI acquired Orchestra Bio, a startup developing AI agents for pharmaceutical drug development.
- OpenAI will integrate Orchestra Bio’s team and technology.
- The acquisition reflects competition between OpenAI and Anthropic to expand into scientific applications.
Why it matters
The deal expands OpenAI’s presence in healthcare and pharmaceutical workflows, potentially increasing competition for AI applications in drug development.
Deal terms
acquisition
OpenAI → Orchestra Bio
Value
—
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
Timeline
- First reported by TechCrunchOct 20OpenAI acquires startup Orchestra Bio to beef up its biotech business
- Axios reportsOct 20Exclusive: OpenAI has acquired Orchestra Bio
- Techmeme reportsOct 20OpenAI acquires Orchestra Bio, which builds AI agents for managing drug development, and plans to integrate its tech into OpenAI life sciences suite Rosalind (Madison Mills/Axios)
- The Information reportsOct 20OpenAI Buys Drug Development Company Orchestra Bio
- Decrypt reportsOct 20OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
Who is involved
acquiringOpenAI acquires startup Orchestra Bio to beef up its biotech…Orchestra BiotargetOpenAIbuyerAnthropic
CompanyThe deal
Sources (5)
- TechCrunchOct 20OpenAI acquires startup Orchestra Bio to beef up its biotech business
- AxiosOct 20Exclusive: OpenAI has acquired Orchestra Bio
- TechmemeOct 20OpenAI acquires Orchestra Bio, which builds AI agents for managing drug development, and plans to integrate its tech into OpenAI life sciences suite Rosalind (Madison Mills/Axios)
- The InformationOct 20OpenAI Buys Drug Development Company Orchestra Bio
- DecryptOct 20OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
- Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
- Follow developing storiesAn alert, and a push, the moment a story you follow moves.
- Your briefing, read aloudA few minutes each morning with a chapter per story.
- Brief modeSwipe through the day, a 20-second card each.